ArticleAnnals of work exposures and health2023
Workplace Exposure Measurements of Emission from Industrial 3D Printing.
Article in Annals of work exposures and health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 12 citations in OpenAlex.
- Occupational Contact Allergy to Components of Epoxy Resin Systems: Descriptive and Comparative Epidemiological Analyses Based on IVDK Data 2008-2022.Contact dermatitis · 2026Article
- Evaluating Dermal Bioactivity of Metal Additive Manufacturing Powders Using HumanChemical research in toxicology · 2026Article
- Operation-specific and time-resolved monitoring of occupational nano/sub-micron particle exposure in a Swedish metal additive manufacturing facility.Annals of work exposures and health · 2026Article
- Using particle dimensionality-based modeling to estimate lung carcinogenicity of 3D printer emissions.Journal of applied toxicology : JAT · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Particle and gaseous contaminants from industrial scale additive manufacturing (AM) machines were studied in three different work environments. Workplaces utilized powder bed fusion, material extrusion, and binder jetting techniques with metal and polymer powders, polymer filaments, and gypsum powder, respectively. The AM processes were studied from operator's point of view to identify exposure events and possible safety risks. Total number of particle concentrations were measured in the range of 10 nm to 300 nm from operator's breathing zone using portable devices and in the range of 2.5 nm to 10 µm from close vicinity of the AM machines using stationary measurement devices. Gas-phase compounds were measured with photoionization, electrochemical sensors, and an active air sampling method which were eventually followed by laboratory analyses. The duration of the measurements varied from 3 to 5 days during which the manufacturing processes were practically continuous. We identified several work phases in which an operator can potentially be exposed by inhalation (pulmonary exposure) to airborne emissions. A skin exposure was also identified as a potential risk factor based on the observations made on work tasks related to the AM process. The results confirmed that nanosized particles were present in the breathing air of the workspace when the ventilation of the AM machine was inadequate. Metal powders were not measured from the workstation air thanks to the closed system and suitable risk control procedures. Still, handling of metal powders and AM materials that can act as skin irritants such as epoxy resins were found to pose a potential risk for workers. This emphasizes the importance of appropriate control measures for ventilation and material handling that should be addressed in AM operations and environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.